Dynavax Historical Balance Sheet

DVAX Stock  USD 12.91  0.25  1.97%   
Trend analysis of Dynavax Technologies balance sheet accounts such as Other Assets of 3 M or Common Stock Shares Outstanding of 135.2 M provides information on Dynavax Technologies' total assets, liabilities, and equity, which is the actual value of Dynavax Technologies to its prevalent stockholders. By breaking down trends over time using Dynavax Technologies balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Dynavax Technologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Dynavax Technologies is a good buy for the upcoming year.

Dynavax Technologies Inventory

55.95 Million

  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

About Dynavax Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Dynavax Technologies at a specified time, usually calculated after every quarter, six months, or one year. Dynavax Technologies Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Dynavax Technologies and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Dynavax currently owns. An asset can also be divided into two categories, current and non-current.

Dynavax Technologies Balance Sheet Chart

At this time, Dynavax Technologies' Property Plant And Equipment Net is fairly stable compared to the past year. Net Debt is likely to rise to about 112 M in 2024, despite the fact that Retained Earnings are likely to grow to (884.1 M).

Total Assets

Total assets refers to the total amount of Dynavax Technologies assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Dynavax Technologies books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.
Most accounts from Dynavax Technologies' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Dynavax Technologies current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dynavax Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.At this time, Dynavax Technologies' Property Plant And Equipment Net is fairly stable compared to the past year. Net Debt is likely to rise to about 112 M in 2024, despite the fact that Retained Earnings are likely to grow to (884.1 M).
 2021 2022 2023 2024 (projected)
Total Liabilities816.9M404.8M375.0M393.8M
Other Stockholder Equity1.4B1.5B1.6B1.6B

Dynavax Technologies balance sheet Correlations

0.85-0.49-0.220.930.810.860.740.610.130.830.80.640.190.910.920.620.110.840.740.970.220.870.880.970.84
0.85-0.21-0.240.740.670.480.370.170.040.490.960.230.210.610.710.20.180.480.360.940.250.650.740.930.59
-0.49-0.210.48-0.73-0.87-0.63-0.53-0.46-0.67-0.45-0.26-0.420.02-0.74-0.7-0.39-0.36-0.57-0.49-0.390.01-0.6-0.64-0.41-0.41
-0.22-0.240.48-0.25-0.49-0.14-0.17-0.18-0.27-0.21-0.2-0.16-0.41-0.28-0.22-0.160.08-0.18-0.16-0.22-0.410.01-0.19-0.21-0.14
0.930.74-0.73-0.250.930.860.740.560.330.740.730.60.080.940.980.530.320.830.720.870.110.910.910.880.8
0.810.67-0.87-0.490.930.720.580.430.530.590.690.430.080.880.890.40.370.670.550.770.110.790.870.790.6
0.860.48-0.63-0.140.860.720.890.870.190.930.430.860.120.950.860.850.010.950.90.730.130.850.770.750.84
0.740.37-0.53-0.170.740.580.890.910.10.930.230.930.090.790.690.86-0.260.970.990.580.090.610.510.570.94
0.610.17-0.46-0.180.560.430.870.91-0.040.930.030.980.130.730.550.99-0.440.90.930.440.130.470.380.430.77
0.130.04-0.67-0.270.330.530.190.1-0.04-0.010.17-0.13-0.080.360.28-0.10.540.080.020.12-0.060.350.430.14-0.03
0.830.49-0.45-0.210.740.590.930.930.93-0.010.360.940.120.850.710.93-0.340.950.940.720.130.650.580.70.88
0.80.96-0.26-0.20.730.690.430.230.030.170.360.080.20.590.720.070.40.360.220.910.240.710.810.910.44
0.640.23-0.42-0.160.60.430.860.930.98-0.130.940.080.140.720.580.97-0.440.920.960.480.130.480.380.460.84
0.190.210.02-0.410.080.080.120.090.13-0.080.120.20.140.090.120.15-0.010.150.160.21.00.010.090.190.19
0.910.61-0.74-0.280.940.880.950.790.730.360.850.590.720.090.930.720.150.880.790.820.110.890.890.830.77
0.920.71-0.7-0.220.980.890.860.690.550.280.710.720.580.120.930.540.370.810.690.850.150.930.940.870.76
0.620.2-0.39-0.160.530.40.850.860.99-0.10.930.070.970.150.720.54-0.470.860.890.470.160.470.380.460.73
0.110.18-0.360.080.320.370.01-0.26-0.440.54-0.340.4-0.44-0.010.150.37-0.47-0.13-0.270.150.010.470.510.2-0.14
0.840.48-0.57-0.180.830.670.950.970.90.080.950.360.920.150.880.810.86-0.130.980.690.160.730.650.690.95
0.740.36-0.49-0.160.720.550.90.990.930.020.940.220.960.160.790.690.89-0.270.980.580.160.60.510.570.94
0.970.94-0.39-0.220.870.770.730.580.440.120.720.910.480.20.820.850.470.150.690.580.230.820.861.00.72
0.220.250.01-0.410.110.110.130.090.13-0.060.130.240.131.00.110.150.160.010.160.160.230.040.120.220.19
0.870.65-0.60.010.910.790.850.610.470.350.650.710.480.010.890.930.470.470.730.60.820.040.960.850.67
0.880.74-0.64-0.190.910.870.770.510.380.430.580.810.380.090.890.940.380.510.650.510.860.120.960.890.59
0.970.93-0.41-0.210.880.790.750.570.430.140.70.910.460.190.830.870.460.20.690.571.00.220.850.890.71
0.840.59-0.41-0.140.80.60.840.940.77-0.030.880.440.840.190.770.760.73-0.140.950.940.720.190.670.590.71
Click cells to compare fundamentals

Dynavax Technologies Account Relationship Matchups

Dynavax Technologies balance sheet Accounts

201920202021202220232024 (projected)
Total Assets279.1M353.3M1.0B985.9M997.1M1.0B
Total Stockholder Equity8.3M58.7M222.4M581.0M622.1M653.2M
Retained Earnings(1.2B)(1.3B)(1.2B)(924.2M)(930.6M)(884.1M)
Other Assets3.6M3.8M368.9K3.5M3.2M3.0M
Common Stock Shares Outstanding72.0M100.8M133.0M150.8M128.7M135.2M
Liabilities And Stockholders Equity279.1M353.3M1.0B985.9M997.1M1.0B
Other Stockholder Equity1.2B1.4B1.4B1.5B1.6B1.6B
Total Liab270.8M294.6M816.9M404.8M375.0M393.8M
Other Current Liab43.8M32.6M201.4M143.2M52.5M30.8M
Total Current Liabilities53.0M77.4M556.4M150.1M62.2M58.2M
Accounts Payable9.3M3.3M2.6M3.2M5.2M3.1M
Cash39.9M32.1M436.2M202.0M150.3M157.8M
Short Term Investments111.2M133.0M109.8M422.4M592.0M621.6M
Other Current Assets(8.9M)38.6M233.4M85.6M19.0M21.4M
Common Stock84K110K123K128K130K83.9K
Property Plant Equipment32.0M30.6M61.0M37.6M43.2M45.4M
Property Plant And Equipment Net32.0M57.2M61.0M63.3M61.6M64.7M
Net Debt176.6M185.8M(178.8M)56.0M106.6M112.0M
Non Current Assets Total86.7M124.5M432.0M302.0M138.0M144.9M
Non Currrent Assets Other50.1M65.1M368.9M236.7M74.3M46.8M
Cash And Short Term Investments151.1M165.0M546.0M624.4M742.3M779.4M
Common Stock Total Equity84K110K123K128K147.2K85.0K
Non Current Liabilities Total217.7M217.2M260.5M254.8M312.8M328.5M
Property Plant And Equipment Gross62.3M57.2M61.0M63.3M93.4M98.1M
Total Current Assets192.4M228.7M607.3M683.8M859.1M902.1M
Accumulated Other Comprehensive Income(2.4M)273K(2.3M)(5.4M)(2.1M)(2.2M)
Net Receivables8.9M22.7M131.8M147.5M44.5M46.8M
Other Liab1.3M2.6M5.7M384K345.6K328.3K
Good Will2.1M2.3M2.1M2.0M2.1M1.8M
Inventory41.3M63.7M61.3M59.4M53.3M56.0M
Short Long Term Debt Total216.4M217.8M257.4M258.0M256.9M148.9M
Long Term Debt178.6M179.8M220.5M221.6M222.7M233.8M
Net Tangible Assets3.7M56.4M220.2M579.0M665.9M699.2M
Retained Earnings Total Equity(1.2B)(1.3B)(1.2B)(924.2M)(831.8M)(873.4M)
Capital Surpluse1.2B1.4B1.4B1.5B1.7B1.1B
Non Current Liabilities Other39.1M37.4M5.7M33.2M74K70.3K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.